Mark Fereshteh
Mark Fereshteh publishes mostly in Oncology, Molecular Biology and Immunology, on topics such as Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses and CAR-T cell therapy research.
- World rank
- #1,399,112 of 7,710,434 ranked researchers
- Rank in United States
- #441,877 of 1,627,098
- Works
- 82
- Citations
- 2.3k
- Citations per work
- 27.7
What does Mark Fereshteh research?
Mark Fereshteh's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (23%), Immunology and Microbiology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3137.8%
- Medicine3137.8%
- Life Sciences2935.2%
- Everything else2227.0%
- 1Oncology27% of their works
- 2Molecular Biology19% of their works
- 3Immunology12% of their works
- 4Radiology, Nuclear Medicine and Imaging8% of their works
- 5Genetics4% of their works
- 6Psychiatry and Mental health3% of their works
Research topics
Which keywords describe Mark Fereshteh's research?
The keywords of their largest research topics: Cancer Immunotherapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Lymphoma, Breast Cancer, Dendritic Cells, Immunity and CAR T Cells.
- Receptor
- HER2
- Classification
- Single-Cell
- Fc Receptors
- CAR T Cells
- Dendritic Cells
- Lymphoma
- Immune Checkpoint Blockade
- Cancer Immunotherapy
- PD-1 and PD-L1
- Breast Cancer
- Immunity
- Chimeric Antigen Receptor
- Therapeutic Antibodies
- Transcriptomics
- Estrogen
- Molecular Profiling
- Trastuzumab
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Cancer Immunotherapy192 topics
- Immune Checkpoint Blockade191 topic
- PD-1 and PD-L1191 topic
- Lymphoma142 topics
- Breast Cancer102 topics
- Dendritic Cells101 topic
- Immunity101 topic
- CAR T Cells91 topic
- Chimeric Antigen Receptor91 topic
- Fc Receptors81 topic
- Therapeutic Antibodies81 topic
- Single-Cell71 topic
- Transcriptomics71 topic
- Classification51 topic
- Estrogen51 topic
- HER251 topic
- Molecular Profiling51 topic
- Receptor51 topic
- Trastuzumab51 topic
Where does Mark Fereshteh work?
Mark Fereshteh's main affiliation in the publication record is Genmab (United States), United States.
How many publications and citations does Mark Fereshteh have?
OpenAlex counts 82 works and 2,273 citations for Mark Fereshteh, an h-index of 17, ranking #1,399,112 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark Fereshteh. Posts are plain text and can be reported.